Connect your AI

CareDx CDNA Available-for-Sale Securities (Non-Current)

Available-for-Sale Securities (Non-Current) at other companies

TrupanionTRUP

$986K+162%

HubbellHUBB

$99.8M+14.8%

Teradyne, Inc.TER

$148.37M+30.4%

Nurix Therapeutics, Inc.NRIX

$469.54M-0.9%

Hims & Hers HealthHIMS

$0—

Royalty PharmaRPRX

$406.8M+85.8%

Other financials

Income statement

Revenue$117.7M+39.0%

Operating income$1.2M+109%

Net income$2.8M+127%

EPS (diluted)$0.05+126%

Balance sheet

Cash & equivalents$78.5M-12.1%

Total debt$24.5M-19.1%

Total equity$313.5M-17.3%

Total assets$411.1M-16.0%

Cash flow

Operating cash flow$4.3M+116%

CapEx$3.8M+134%

Free cash flow$514.0K+102%

Valuation

Market cap$1.44B+35.7%

Enterprise value$1.38B+38.3%

P/S3.5×+0.4×

Profitability

Gross margin65.5%—

Operating margin-3.9%-18.3pp

Net margin-2%-19.9pp

FCF margin-0%0.0pp

Returns & leverage

Return on equity-2.4%-21.9pp

Debt / equity0.1×0.0×

Current ratio3.4×-0.7×

Where this comes from

Reported directly by CareDx in its filing.

Tagged under the XBRL concept us-gaap:MarketableSecuritiesNoncurrent.

The official record: CareDx’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about CareDx's available-for-sale securities (non-current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is CareDx's available-for-sale securities (non-current)?: CareDx (CDNA) reported available-for-sale securities (non-current) of $10.9M in Q1 2026.